Detection of anti-domain I antibodies by chemiluminescence enables the identification of high-risk antiphospholipid syndrome patients: A multicenter multiplatform study

Dongmei Yin, Walid Chayoua, Hilde Kelchtermans, Philip G. de Groot, Gary W. Moore, Jean-Christophe Gris, Stephane Zuily, Jacek Musial, Bas de Laat, Katrien M. J. Devreese*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)463-478
Number of pages16
JournalJournal of Thrombosis and Haemostasis
Volume18
Issue number2
DOIs
Publication statusPublished - Feb 2020

Keywords

  • antiphospholipid syndrome
  • beta 2-glycoprotein I
  • domain I
  • multicenter
  • pregnancy morbidity
  • thrombosis
  • BETA(2)-GLYCOPROTEIN I
  • IGG ANTIBODIES
  • AUTOIMMUNE-DISEASES
  • BETA-2-GLYCOPROTEIN-I
  • THROMBOSIS
  • DIAGNOSIS
  • AUTOANTIBODIES
  • PATHOGENICITY
  • IMMUNOASSAY
  • ASSOCIATION

Cite this